Q32 Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Q32 Bio (Nasdaq: QTTB) said management will appear in a fireside chat at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Wednesday, February 25, 2026 at 2:00 p.m. ET.

Rhea-AI Summary

Q32 Bio (Nasdaq: QTTB) said management will appear in a fireside chat at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Wednesday, February 25, 2026 at 2:00 p.m. ET.

A live webcast will be available on Q32 Bio's Events and Presentations page, with archived replays accessible for 90 days after the event.

Argus Feb 18 session

-5.37% close to close Open Argus

Details

News Market Reaction – QTTB

On Feb 18, the day this news came out, QTTB closed 5.37% below the previous close.

Data tracked by StockTitan Argus for the Feb 18 session.

Key Figures

Conference time: 2:00 p.m. E.T. Conference date: February 25, 2026 Conference edition: 36th +1 more

Conference time

2:00 p.m. E.T.

Scheduled fireside chat on February 25, 2026

Conference date

February 25, 2026

Oppenheimer 36th Annual Healthcare Life Sciences Conference

Conference edition

36th

Oppenheimer Annual Healthcare Life Sciences Conference

Replay window

90 days

Archived webcast replay availability after the event

Historical Context

4 past events · Latest: Dec 01

4 events

1. Dec 01

   Asset sale / funding

   24h Move

   +74.4%

   Sold ADX-097 with upfront, milestones and royalties extending cash runway.

2. Nov 13

   Earnings and update

   24h Move

   -9.1%

   Reported Q3 2025 results and progress on SIGNAL-AA Part B enrollment.

3. Oct 21

   Clinical trial update

   24h Move

   -10.8%

   Completed Part B enrollment in SIGNAL-AA Phase 2a for bempikibart in AA.

4. Aug 28

   Conference participation

   24h Move

   +2.9%

   Announced Wells Fargo Healthcare Conference fireside chat and webcast access.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

alopecia areata (aa)

1 terms

alopecia areata (aa) medical

"developing innovative therapies for alopecia areata (AA) and other autoimmune"

Alopecia areata is an autoimmune condition that causes hair to fall out in round patches when the immune system mistakenly attacks hair follicles; it can range from small bald spots to complete loss of scalp or body hair. Investors care because the condition creates a measurable patient population and ongoing demand for treatments, so trial results, regulatory decisions, or new therapies can meaningfully affect company sales and valuation—like a small market shift triggering larger ripples in a pond.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., Feb. 18, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced that management will participate in a fireside chat at 2:00 p.m. E.T. on Wednesday, February 25, 2026 at the Oppenheimer 36^th Annual Healthcare Life Sciences Conference.

A webcast of the presentation will be available on the Events and Presentations page of Q32 Bio's website at www.q32bio.com. Archived replays will be available for 90 days following the event.

About Q32 Bio

Q32 Bio is a clinical stage biotechnology company whose science targets potent regulators of the adaptive immune system to re-balance immunity and is focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases. About 700,000 people in the United States live with alopecia areata¹, a disease which has a life-altering impact on patients and limited current treatment options. Q32 Bio is advancing bempikibart (ADX-914), a fully human anti-IL-7Rα antibody that re-regulates adaptive immune function, for the treatment of alopecia areata in an ongoing Phase 2 program. The IL-7 and TSLP pathways have been genetically and biologically implicated in driving several T cell-mediated pathological processes in numerous autoimmune diseases.

For more information, visit www.Q32Bio.com.

¹National Alopecia Areata Foundation

Availability of Other Information About Q32 Bio

Investors and others should note that Q32 Bio communicates with its investors and the public using its website www.Q32Bio.com, including, but not limited to, Q32 Bio's disclosures, investor presentations and FAQs, Securities and Exchange Commission (the "SEC") filings, press releases, public conference call transcripts and webcast transcripts, as well as on X (formerly Twitter) and LinkedIn. The information that Q32 Bio posts on its website or on X or LinkedIn could be deemed to be material information. As a result, Q32 Bio encourages investors, the media and others interested to review the information that it posts there on a regular basis. The contents of Q32 Bio's website or social media shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Contacts:

Investors: Brendan Burns
Argot Partners
212.600.1902
Q32Bio@argotpartners.com

Media: David Rosen
Argot Partners
646.461.6387
david.rosen@argotpartners.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/q32-bio-to-participate-in-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-302689781.html

SOURCE Q32 Bio

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Q32 Bio (QTTB) present at the Oppenheimer Healthcare Life Sciences Conference?

Q32 Bio will present on Wednesday, February 25, 2026 at 2:00 p.m. ET. According to the company, the session is a fireside chat during the Oppenheimer 36th Annual Healthcare Life Sciences Conference and is aimed at investors and analysts.

How can investors watch Q32 Bio (QTTB) at the February 25, 2026 conference?

Investors can watch via live webcast on Q32 Bio's Events and Presentations webpage. According to the company, the webcast link will be posted on www.q32bio.com and a replay will be available for 90 days.

Will Q32 Bio (QTTB) make the presentation available after the conference?

Yes, an archived replay will be available for 90 days after the event. According to the company, the replay will be posted on the Events and Presentations page of its website for on-demand viewing.

What topics will Q32 Bio (QTTB) likely cover in the February 25, 2026 fireside chat?

The company will discuss its clinical-stage programs in alopecia areata and related autoimmune research. According to the company, management will cover recent progress, development plans, and corporate updates relevant to investors.

Where is the webcast of Q32 Bio's (QTTB) Oppenheimer presentation hosted?

The webcast is hosted on Q32 Bio's Events and Presentations page at www.q32bio.com. According to the company, the page will provide the live stream link and subsequent archived replay for 90 days.